- Trials with a EudraCT protocol (43,871)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (18,700)
43,871 result(s) found.
Displaying page 420 of 2,194.
EudraCT Number: 2011-003544-42 | Sponsor Protocol Number: 2011-3 | Start Date*: 2012-02-16 | |||||||||||
Sponsor Name:Department of Neurosurgery, PMU | |||||||||||||
Full Title: DRES - A prospective, multi-center, double blind, randomized, placebo controlled study to assess the efficacy of Dexamethason in reducing the reoperation rate in patients with chronic subdural hema... | |||||||||||||
Medical condition: operated chronic subdural hematoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-005559-46 | Sponsor Protocol Number: 205MS202 | Start Date*: 2009-01-23 | |||||||||||
Sponsor Name:Biogen Idec Ltd. | |||||||||||||
Full Title: A Double-Blind, Multicenter, Extension Study to Evaluate the Safety and Efficacy of DAC HYP in Subjects with Multiple Sclerosis Who Have Completed Treatment in Study 205MS201 (SELECT) | |||||||||||||
Medical condition: Relapsing-remitting Multiple Sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) HU (Completed) DE (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005482-12 | Sponsor Protocol Number: GLP-1-2012-01 | Start Date*: 2013-04-15 | |||||||||||
Sponsor Name:University College Dublin | |||||||||||||
Full Title: The effect of glucagon-like-peptide 1 (GLP-1) analogues on inflammation in humans with diabetic kidney disease. | |||||||||||||
Medical condition: Diabetic Kidney Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005498-29 | Sponsor Protocol Number: 2.28 | Start Date*: 2013-03-21 |
Sponsor Name:Celica, Biomedical Center, d.o.o. | ||
Full Title: Preparation and application of autologous immunohybridoma cells for the treatment of prostate cancer | ||
Medical condition: Prostate cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: SI (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-005511-11 | Sponsor Protocol Number: SPON1155-12 | Start Date*: 2013-05-07 | ||||||||||||||||||||||||||
Sponsor Name:RACD Cardiff University | ||||||||||||||||||||||||||||
Full Title: Fibrinogen concentrate versus placebo for treatment of postpartum haemorrhage: a prospective double blind randomised control trial | ||||||||||||||||||||||||||||
Medical condition: Postpartum haemorrhage | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-005521-73 | Sponsor Protocol Number: GLPG0974-CL-201 | Start Date*: 2013-03-20 | |||||||||||
Sponsor Name:Galapagos NV | |||||||||||||
Full Title: Exploratory, Phase II, Randomized, Double-blind, Placebo-controlled, Proof-of-Concept study to evaluate the safety, tolerability, efficacy, pharmacokinetics and pharmacodynamics of GLPG0974 in sub... | |||||||||||||
Medical condition: Mild to moderate Ulcerative Colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) CZ (Completed) LV (Completed) | |||||||||||||
Trial results: Removed from public view |
EudraCT Number: 2013-000752-18 | Sponsor Protocol Number: 54767414MMY2002 | Start Date*: 2013-11-04 | |||||||||||
Sponsor Name:Janssen-Cilag International N.V. | |||||||||||||
Full Title: An Open-label, Multicenter, Phase 2 Trial Investigating the Efficacy and Safety of Daratumumab in Subjects With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Pro... | |||||||||||||
Medical condition: Multiple myeloma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001815-21 | Sponsor Protocol Number: ABH_EB-001 | Start Date*: 2013-01-18 | |||||||||||
Sponsor Name:Shire Regenerative Medicine, Inc. | |||||||||||||
Full Title: A Multicenter, Prospective, Randomized, Open-label, Intra-patient Controlled Study of the Efficacy and Safety of ABH001 for the Treatment of Stalled Chronic Cutaneous Wounds Associated with General... | |||||||||||||
Medical condition: Epidermolysis bullosa | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) DE (Prematurely Ended) AT (Completed) PT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023311-34 | Sponsor Protocol Number: CPA 368-10 | Start Date*: 2011-02-04 | |||||||||||
Sponsor Name:AOP Orphan Pharmaceuticals AG | |||||||||||||
Full Title: A prospective, randomized, double blinded, crossover, two-treatment, two-sequence, short term pharmacokinetic, pharmacodynamic and tolerability, single centre study to compare AOP200704 vs. Esmolol... | |||||||||||||
Medical condition: healthy male and female volunteers, intended for the treatment of dobutamine-induced tachycardia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023313-57 | Sponsor Protocol Number: INF | Start Date*: 2012-04-10 |
Sponsor Name:Helsinki University Central Hospital | ||
Full Title: Homing potential of the antigen specific B cell and antibody mediated immune response after vaccination | ||
Medical condition: Basic healthy volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FI (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-001481-18 | Sponsor Protocol Number: 6925 | Start Date*: 2011-10-07 |
Sponsor Name:Uppsala University Hospital | ||
Full Title: Uncemented total hip implant and subcutaneous injection of Denosumab for patients with osteoarthritis of the hip. A randomised double blind placebo controlled study on the effects on bone evaluated... | ||
Medical condition: Patients with osteoarthritis of the hip treated with an uncemented total hip arthroplasty. This procedure is accompanied with an increased risk for loss of bone adjacent to the implants | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-022749-74 | Sponsor Protocol Number: MASTEC-002 | Start Date*: 2011-06-14 | |||||||||||
Sponsor Name:CAROLINA IBAÑEZ LOPEZ | |||||||||||||
Full Title: ANALGESIA POSTOPERATORIA MEDIANTE LA INFUSIÓN DE UN ANESTESICO LOCAL EN EL LECHO QUIRURGICO TRAS MASTECTOMÍA RADICAL MODIFICADA | |||||||||||||
Medical condition: tratamiento del dolor en pacientes sometidas a mastectomia radical | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-022750-16 | Sponsor Protocol Number: 123/2004 | Start Date*: 2010-12-27 | |||||||||||
Sponsor Name:Marjo Renko | |||||||||||||
Full Title: Magnesiumsulfaatti-infuusio lasten äkillisen bronkusobstruktion hoidossa | |||||||||||||
Medical condition: Tutkimukseen rekrytoidaan OYS:n lasten päivystyspoliklinikalle tulevat lapset, joilla hengitystieinfektioon liittyvä bronkusobstruktio, iIkä 0.5- 4 vuotta ja tavanomaisen polikliinisen lääkityksen ... | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-022757-42 | Sponsor Protocol Number: IMM-101-002 | Start Date*: 2011-05-17 | |||||||||||
Sponsor Name:Immodulon Therapeutics Limited | |||||||||||||
Full Title: A Randomised, Open-Label, Proof-of-Concept, Phase II Trial Comparing Gemcitabine with and without IMM-101 in Advanced Pancreatic Cancer | |||||||||||||
Medical condition: Advanced pancreatic cancer The overall objective of this clinical study is to evaluate a potential synergy between gemcitabine and IMM-101 and any beneficial effect this may have on safety and to... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) ES (Completed) IT (Completed) IE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000877-29 | Sponsor Protocol Number: GEOS-01-2011 | Start Date*: 2011-12-02 | |||||||||||
Sponsor Name:Grupo de Estudos Oncológicos | |||||||||||||
Full Title: Phase III clinical trial for evaluation of prophylactic treatment with minocycline versus reactive treatment of dermatological toxicity secondary to cetuximab in patients with metastatic colorectal... | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000897-80 | Sponsor Protocol Number: ABS4986g | Start Date*: 2011-08-16 | |||||||||||
Sponsor Name:Genentech, Inc. | |||||||||||||
Full Title: PHASE II RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF rhuMAb BETA7 IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS | |||||||||||||
Medical condition: Ulcerative colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) CZ (Completed) GB (Prematurely Ended) ES (Prematurely Ended) DE (Completed) HU (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001367-76 | Sponsor Protocol Number: PP095 | Start Date*: 2012-07-18 | |||||||||||
Sponsor Name:PledPharma AB | |||||||||||||
Full Title: A double blinded, randomized, multi centre, three armed phase II trial of PledOx in two different doses in combination with FOLFOX6 compared to placebo + FOLFOX6 in patients with metastatic colorec... | |||||||||||||
Medical condition: Metastatic colorectal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) PT (Completed) DE (Completed) BG (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019058-42 | Sponsor Protocol Number: LITIO-SUM-FC-002 | Start Date*: 2010-05-26 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERO UNIVERSITARIA DI CAGLIARI | |||||||||||||
Full Title: Safety of sumatriptan in combination with lithium for treatment of cluster headache, Pilot Study,Phase II | |||||||||||||
Medical condition: Cluster Headache | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-019060-37 | Sponsor Protocol Number: CH.MAX-FACC.02/2009 | Start Date*: 2010-07-09 | ||||||||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | ||||||||||||||||||
Full Title: Clinical prospective study to evaluate the efficacy of hygienical therapy and metronidazole in addition to antibiotic therapy in patients affected by bisphosponate-associated osteonecrosis of the jaws | ||||||||||||||||||
Medical condition: patients affected by bisphosponate-associated osteonecrosis of the jaws and infection. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-019079-32 | Sponsor Protocol Number: 190342-033D | Start Date*: 2010-05-19 |
Sponsor Name:Allergan Limited | ||
Full Title: A Multicenter, Patient-Masked, Safety Extension Study to Evaluate the Biodegradation of the Brimonidine Tartrate Posterior Segment Drug Delivery System | ||
Medical condition: Patients who participated in a previous intravitreal Brimo PS DDS study, including 190342-028D (Retinitis pigmentosa) and 190342-032D (Geographic Atrophy from Age-related Macular Degeneration). | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: PT (Completed) DE (Completed) GB (Completed) CZ (Completed) IT (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.